Novelion Therapeutics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Novelion Therapeutics (NVLN) Posts Q2 Loss of $0.08 on Revenue of $40.9M
August 8, 2017 7:14 AM EDTNovelion Therapeutics (NASDAQ: NVLN) reported Q2 EPS of ($0.08). Revenue was $40.9 million compared to the prior years second quarter net revenues of $0
2017 Financial Guidance
The Company is revising its previously stated net revenues financial guidance for full year 2017 and now expects:
Total net... More